Both in Pharmaceuticals
Entrada Therapeutics vs ALX Oncology Holdings
Over the past year TRDA returned −30.4% and ALXO returned −17.8%; their daily moves had a correlation of 0.26.
TRDA −30.4% ALXO −17.8%Growth of $1, one year, split-adjusted
| Metric | TRDA | ALXO |
|---|---|---|
| Price | $4.72 | $1.29 |
| Market cap | $183.8M | $178.4M |
| Today | −7.63% | −5.84% |
| 1 month | −13.9% | +6.6% |
| 6 months | −70.0% | −33.2% |
| Year to date | −54.1% | +14.2% |
| 1 year | −32.1% | −16.2% |
| Revenue growth (YoY) | −53.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −4762.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 39.2× | — |
| Net cash | $223.0M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 84.9% | 93.1% |
| Short % of float | 13.0% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).